Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 224

1.

Evaluation of regulated delayed attenuation strategies for Salmonella enterica serovar Typhi vaccine vectors in neonatal and infant mice.

Shi H, Wang S, Curtiss R 3rd.

Clin Vaccine Immunol. 2013 Jun;20(6):931-44. doi: 10.1128/CVI.00003-13. Epub 2013 Apr 24.

2.

A Phase I, dose-escalation trial in adults of three recombinant attenuated Salmonella Typhi vaccine vectors producing Streptococcus pneumoniae surface protein antigen PspA.

Frey SE, Lottenbach KR, Hill H, Blevins TP, Yu Y, Zhang Y, Brenneman KE, Kelly-Aehle SM, McDonald C, Jansen A, Curtiss R 3rd.

Vaccine. 2013 Oct 1;31(42):4874-80. doi: 10.1016/j.vaccine.2013.07.049. Epub 2013 Aug 3.

PMID:
23916987
3.

PspA family fusion proteins delivered by attenuated Salmonella enterica serovar Typhimurium extend and enhance protection against Streptococcus pneumoniae.

Xin W, Li Y, Mo H, Roland KL, Curtiss R 3rd.

Infect Immun. 2009 Oct;77(10):4518-28. doi: 10.1128/IAI.00486-09. Epub 2009 Aug 17.

5.

Evaluation of new generation Salmonella enterica serovar Typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspA.

Li Y, Wang S, Scarpellini G, Gunn B, Xin W, Wanda SY, Roland KL, Curtiss R 3rd.

Proc Natl Acad Sci U S A. 2009 Jan 13;106(2):593-8. doi: 10.1073/pnas.0811697106. Epub 2008 Dec 29.

6.
7.

Analysis of type II secretion of recombinant pneumococcal PspA and PspC in a Salmonella enterica serovar Typhimurium vaccine with regulated delayed antigen synthesis.

Xin W, Wanda SY, Li Y, Wang S, Mo H, Curtiss R 3rd.

Infect Immun. 2008 Jul;76(7):3241-54. doi: 10.1128/IAI.01623-07. Epub 2008 May 5.

8.
10.

A bivalent conjugate vaccine containing PspA families 1 and 2 has the potential to protect against a wide range of Streptococcus pneumoniae strains and Salmonella Typhi.

Kothari N, Kothari S, Choi YJ, Dey A, Briles DE, Rhee DK, Carbis R.

Vaccine. 2015 Feb 4;33(6):783-8. doi: 10.1016/j.vaccine.2014.12.032. Epub 2014 Dec 26.

PMID:
25545593
11.

Immune responses to recombinant pneumococcal PsaA antigen delivered by a live attenuated Salmonella vaccine.

Wang S, Li Y, Shi H, Scarpellini G, Torres-Escobar A, Roland KL, Curtiss R 3rd.

Infect Immun. 2010 Jul;78(7):3258-71. doi: 10.1128/IAI.00176-10. Epub 2010 May 17.

12.

Immunogenicity of a live recombinant Salmonella enterica serovar typhimurium vaccine expressing pspA in neonates and infant mice born from naive and immunized mothers.

Shi H, Wang S, Roland KL, Gunn BM, Curtiss R 3rd.

Clin Vaccine Immunol. 2010 Mar;17(3):363-71. doi: 10.1128/CVI.00413-09. Epub 2010 Jan 6.

13.

Systemic and mucosal immunity induced by attenuated Salmonella enterica serovar Typhimurium expressing ORF7 of porcine reproductive and respiratory syndrome virus.

Han YW, Kim SB, Rahman M, Uyangaa E, Lee BM, Kim JH, Park KI, Hong JT, Han SB, Eo SK.

Comp Immunol Microbiol Infect Dis. 2011 Jul;34(4):335-45. doi: 10.1016/j.cimid.2011.04.001. Epub 2011 May 2.

PMID:
21543119
14.

Evaluation of Salmonella enterica serovar Typhimurium and Choleraesuis slyA mutant strains for use in live attenuated oral vaccines.

Haneda T, Okada N, Kikuchi Y, Takagi M, Kurotaki T, Miki T, Arai S, Danbara H.

Comp Immunol Microbiol Infect Dis. 2011 Sep;34(5):399-409. doi: 10.1016/j.cimid.2011.07.001. Epub 2011 Aug 12.

PMID:
21840053
15.

Nanogel-based PspA intranasal vaccine prevents invasive disease and nasal colonization by Streptococcus pneumoniae.

Kong IG, Sato A, Yuki Y, Nochi T, Takahashi H, Sawada S, Mejima M, Kurokawa S, Okada K, Sato S, Briles DE, Kunisawa J, Inoue Y, Yamamoto M, Akiyoshi K, Kiyono H.

Infect Immun. 2013 May;81(5):1625-34. doi: 10.1128/IAI.00240-13. Epub 2013 Mar 4.

16.
17.

Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.

Fraillery D, Baud D, Pang SY, Schiller J, Bobst M, Zosso N, Ponci F, Nardelli-Haefliger D.

Clin Vaccine Immunol. 2007 Oct;14(10):1285-95. Epub 2007 Aug 8.

18.
19.

Mucosal immunization with an unadjuvanted vaccine that targets Streptococcus pneumoniae PspA to human Fcγ receptor type I protects against pneumococcal infection through complement- and lactoferrin-mediated bactericidal activity.

Bitsaktsis C, Iglesias BV, Li Y, Colino J, Snapper CM, Hollingshead SK, Pham G, Gosselin DR, Gosselin EJ.

Infect Immun. 2012 Mar;80(3):1166-80. doi: 10.1128/IAI.05511-11. Epub 2011 Dec 12.

20.

A colanic acid operon deletion mutation enhances induction of early antibody responses by live attenuated Salmonella vaccine strains.

Wang S, Shi H, Li Y, Shi Z, Zhang X, Baek CH, Mothershead T, Curtiss R 3rd.

Infect Immun. 2013 Sep;81(9):3148-62. doi: 10.1128/IAI.00097-13. Epub 2013 Jun 17.

Items per page

Supplemental Content

Write to the Help Desk